Wyeth secures Australian injunction against MSD vaccine
30-11-2020
Australian court issues mixed vaccine patent ruling
15-10-2020
Appeals court sides with Pfizer, Merck KGaA in $5bn suit
29-09-2020
Atmosphere1 / Shutterstock.com
The English High Court has concluded that Merck Sharp Dohme (MSD) is not infringing a patent owned by Pfizer through the sale of its pneumococcal conjugate vaccine.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
MSD, Merck Sharp Dohme, Wyeth, Pfizer, vaccine, patent infringement, patent invalidity, English High Court
